Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
Elevance Health is the only health insurance company of 10 Moody's Ratings evaluated that received a "positive" credit ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...
The major holdouts were the two largest PBMs besides CVS Caremark: UnitedHealth-owned Optum Rx and Cigna-owned Express Scripts, according to CVS CFO Tom Cowhey. However, it’s normal for ...
FTC said the "Big 3 PBMs" — CVS’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx — imposed markups of hundreds to thousands of percent on critical drugs, including those ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal Trade Commission (FTC) uncovered in its second interim staff report ...